Use fundamental data analysis to confirm all available indicators of Virtus LifeSci Biotech to find out if markets are presently mispricing the entity. We found ten available drivers for Virtus LifeSci Biotech Products which can be compared to its competition. Please use Virtus LifeSci Price to Earning, Total Asset as well as the relationship between Total Asset and Equity Positions Weight to make a decision on weather Virtus LifeSci Biotech is priced fairly. Use Virtus LifeSci to enhance returns of your portfolios. The etf experiences moderate upward volatility. Check odds of Virtus LifeSci to be traded at $42.59 in 30 days.
Virtus LifeSci Company Summary
Virtus LifeSci competes with Vanguard Health, iShares Nasdaq, iShares U, SPDR Series, and First Trust. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Virtus LifeSci is traded on BATS Exchange in USA.
Virtus LifeSci Price to Book vs Net Asset
Virtus LifeSci Biotech Products is rated below average in price to book as compared to similar ETFs. It is rated below average in net asset as compared to similar ETFs making up about 16,813,253 of Net Asset per Price to Book.
|Price to Book ( times )|
Virtus LifeSci Biotech Systematic Risk
Virtus LifeSci Thematic Clasifications
Virtus LifeSci September 19, 2019 Opportunity Range